Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Daniel Erskine
Newcastle Authors
Title
Year
Full text
Dr Clare Tweedy
Nathan Kindred
Professor John-Paul Taylor
Dr Daniel Erskine
Dr Christopher Morris
et al.
Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein
2021
Chris Hatton
Dr Amy Reeve
Dr Nichola Lax
Dr Alasdair Blain
Dr Yi Ng
et al.
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
2020
Dr Kirsty McAleese
Dr Lauren Walker
Dr Daniel Erskine
Mary Johnson
Dr David Koss
et al.
Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden
2020
Dr Daniel Erskine
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity
2020
Dr Daniel Erskine
Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies
2020
Dr Daniel Erskine
Dr Christopher Morris
Professor Johannes Attems
Investigating the Presence of Doubly‐phosphorylated α‐Synuclein at Tyrosine 125 and Serine 129 In Idiopathic Lewy Body Diseases
2020
Dr Daniel Erskine
Antibodies against alpha‐synuclein: tools and therapies
2019
Dr Daniel Erskine
Professor John-Paul Taylor
Cholinergic muscarinic M
1
and M
4
receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders
2019
Professor Tiago Outeiro
Dr David Koss
Dr Daniel Erskine
Dr Lauren Walker
Dr Marzena Kurzawa-Akanbi
et al.
Dementia with Lewy bodies: an update and outlook
2019
Dr Kirsty McAleese
Madhurima Dey
Dr Lauren Walker
Dr Daniel Erskine
Mary Johnson
et al.
Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease
2019
1
2
3